Zobrazeno 1 - 10
of 756
pro vyhledávání: ''
Autor:
Bronwyn Lester, Peter D. Drummond
Publikováno v:
European Neuropsychopharmacology. 28:1284-1288
The aim of this study was to determine whether loratadine, a selective inverse agonist of peripheral histamine H1 receptors, would reduce emotional blushing. Loratadine (10 mg) or placebo was administered orally one hour before 31 healthy participant
Autor:
Simone Grimm, Ana Lucia Herrera-Melendez, Erich Seifritz, Matti Gärtner, Malek Bajbouj, Christian Otte, Milan Scheidegger, Sabine Aust, Isabella Heuser-Collier, Anna Stippl
Publikováno v:
European Neuropsychopharmacology
Ketamine was recently approved for treatment resistant depression. However, despite its therapeutic potential, about 50% of patients do not show improvement under this therapy. In this prospective two-site study, we investigated baseline brain struct
Publikováno v:
European neuropsychopharmacology, 28(9), 1024-1034. Elsevier
Long-stay patients with severe schizophrenia are frequently treated with high doses of first-generation antipsychotics (FGA). Dose reduction or switching to ziprasidone may reduce the severity of negative symptoms and side effects. We investigated in
Publikováno v:
European Neuropsychopharmacology. 27:1042-1053
Proceeding from a biophysical network model, the present study hypothesized that glutamatergic neurotransmission across the NMDA receptor (NMDAR) plays a key role in visual perception and its modulation by acute stress. To investigate these hypothese
Publikováno v:
European Neuropsychopharmacology. 40:S136-S137
Autor:
Alessandro Crippa, Eleonora Maggioni, M. Pozzi, Paolo Brambilla, E. Rosi, Vaibhav A. Diwadkar, F.M. Villa, M. Molteni, M. Mauri, S. Grazioli, M. Nobile, A. Bacchetta
Publikováno v:
European Neuropsychopharmacology. 40:S34-S35
Autor:
Tien-Yu Chen, Wei-Cheng Yang, Philip Chik-keung Chow, Pao-Yen Lin, Ching-Kuan Wu, Ping-Tao Tseng, Che-Sheng Chu, Fu-Chiang Wang, Chia-Hung Tang, Dian-Jeng Li
Publikováno v:
European Neuropsychopharmacology. 27:29-41
Add-on ketamine anesthesia in electroconvulsive therapy (ECT) has been studied in depressive patients in several clinical trials with inconclusive findings. Two most recent meta-analyses reported insignificant findings with regards to the treatment e
Autor:
Markus Wöhr, Luiz Kae Sales Kanazawa, Palloma de Almeida Soares Hocayen, Etieli Wendler, Rainer K.W. Schwarting, Débora Dalla Vecchia, Roberto Andreatini, Camila Pasquini de Souza
Publikováno v:
European Neuropsychopharmacology. 26:1900-1908
Drug-induced hyperlocomotion in rodents is frequently used as a behavioral model for mania. However, the use of locomotor activity as the single parameter in these animal models of mania may pose some limitations for developing new pharmacological tr
Autor:
Arie Struyk, Cynthia Gargano, Junshui Ma, David Mayleben, S. Aubrey Stoch, Vladimir Svetnik, Melissa Drexel
Publikováno v:
European Neuropsychopharmacology. 26:1649-1656
The objective of this study was to evaluate sleep electrophysiology in healthy subjects after bedtime administration of therapeutic doses of two insomnia treatments - the orexin receptor antagonist suvorexant or the GABAergic agonist zolpidem. Eighte
Autor:
Sylvie Bernaerts, Kaat Alaerts
Publikováno v:
European Neuropsychopharmacology. 29:S358-S359